Gene: PRAC2
Official Full Name: PRAC2 small nuclear proteinprovided by HGNC
Gene Summary: This gene is highly expressed in prostate, rectum, colon, and testis. This gene may produce a non-coding RNA or may encode a short protein that might localize to the nucleus. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21551 | PRAC2 Knockout cell line (HEK293) | Human | PRAC2 | 1:3~1:6 | Negative | Online Inquiry |
PRAC2 Gene Knockout Cell Lines are specialized cellular models created through advanced gene editing techniques, specifically designed to investigate the functional role of the PRAC2 gene in various biological processes. These cell lines feature a targeted deletion of the PRAC2 gene, effectively silencing its expression and allowing for an in-depth study of the resulting phenotypic changes.
The key functions of PRAC2 Gene Knockout Cell Lines lie in their ability to elucidate the gene's involvement in cellular signaling pathways, differentiation, and disease mechanisms. By nullifying the PRAC2 gene, researchers can observe how its absence affects cellular behavior, gene expression profiles, and overall physiology. This dynamic allows for the exploration of novel therapeutic targets, enabling scientists to design more effective strategies for disease intervention.
The scientific importance of these cell lines cannot be overstated, particularly in the context of cancer research, neurological disorders, and various metabolic diseases where the PRAC2 gene is implicated. Their applications span foundational research, drug discovery, and preclinical testing, all of which are crucial for advancing therapeutic developments.
When compared to conventional cell models, our PRAC2 Gene Knockout Cell Lines offer significant advantages such as high specificity and reproducibility, which are essential for producing reliable data. Their unique selling point lies in their capacity for versatile application, engaging a broad range of research interests, and providing insights into gene function that can lead to breakthroughs in understanding complex biological systems.
Researchers and clinicians will find immense value in these cell lines as they facilitate deeper explorations into genetic contributions to disease, ultimately driving innovation in clinical treatments. By investing in these knockout cell lines, users gain access to an unparalleled tool in genetic research.
With a proven track record in developing advanced biological products, our company is committed to supporting researchers and clinicians with high-quality, scientifically validated tools that enhance the exploration of gene functions and contribute to transformative breakthroughs in medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.